Success Metrics

Clinical Success Rate
57.1%

Based on 4 completed trials

Completion Rate
57%(4/7)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Terminated
3(27%)

Phase Distribution

Ph phase_3
1
9%
Ph not_applicable
3
27%
Ph phase_2
2
18%
Ph phase_1
3
27%

Phase Distribution

3

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
3(33.3%)
Phase 2Efficacy & side effects
2(22.2%)
Phase 3Large-scale testing
1(11.1%)
N/ANon-phased studies
3(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

44.4%

4 of 9 finished

Non-Completion Rate

55.6%

5 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(4)
Terminated(5)
Other(2)

Detailed Status

Completed4
Terminated3
Withdrawn2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
57.1%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (33.3%)
Phase 22 (22.2%)
Phase 31 (11.1%)
N/A3 (33.3%)

Trials by Status

terminated327%
withdrawn218%
unknown218%
completed436%

Recent Activity

0 active trials
Showing 5 of 11
completedphase_1

Chemoembolization for Lung Tumors

NCT04200417
withdrawnnot_applicable

BioPearl™ Microspheres Loaded With Doxorubicin: Prospective, Single Arm, Multi-centre Post-market Follow-up Study.

NCT04231929
completed

DC Bead LUMI (TM) Loaded With Doxorubicin for Intermediate Hepatocellular Carcinoma (HCC)

NCT03474354
unknown

Prevention and Treatment of Complications of Endovascular Methods in Patients With Malignant Liver Tumors

NCT04764409
terminatedphase_2

LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma

NCT02524119
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT04200417Phase 1

Chemoembolization for Lung Tumors

Completed
NCT04231929Not Applicable

BioPearl™ Microspheres Loaded With Doxorubicin: Prospective, Single Arm, Multi-centre Post-market Follow-up Study.

Withdrawn
NCT03474354

DC Bead LUMI (TM) Loaded With Doxorubicin for Intermediate Hepatocellular Carcinoma (HCC)

Completed
NCT04764409

Prevention and Treatment of Complications of Endovascular Methods in Patients With Malignant Liver Tumors

Unknown
NCT02524119Phase 2

LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma

Terminated
NCT02470533Phase 2

Transarterial Chemoembolization Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma

Terminated
NCT02548780Not Applicable

LifePearl-Doxo Pharmacokinetic (PK) Study

Completed
NCT01336985Phase 1

Safety and Pharmacokinetics of Treating Liver Cancer With Drug-Eluting Beads

Terminated
NCT03277716Not Applicable

Microwave Ablation Combined With TACE in the Treatment of Unresectable Huge Hepatocellular Carcinoma Huge

Unknown
NCT02149771Phase 3

Combination Treatment for Advanced Liver Cancer

Withdrawn
NCT02870010Phase 1

Chemoembolization of Non-resectable Non-metastatic Hepatocellular Carcinoma Using Embolization Microspheres

Completed

All 11 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
11